MGRC Subsidiary Signs Two Collaboration Agreements To Explore Genetic Screening Services
MGRC Subsidiary Signs Two Collaboration Agreements To Explore Genetic Screening Services
Malaysian Genomics Resource Centre Berhad's (MGRC) wholly owned subsidiary MGRC Healthcare Sdn Bhd (MGRCH) has entered into two separate collaboration agreements for the purpose of establishing strategic partnerships between the parties and to explore the possibility of cooperations for genetic screening services known as "Origene All-in-One Report" including a derivative product known as "Childhood-Onset Disease Profile" for the cell-gene therapies in respective diseases
马来西亚基因组资源中心有限公司（MGRC）的全资子公司MGRC Healthcare Sdn Bhd（MGRCH）已签订了两份单独的合作协议，目的是建立双方之间的战略伙伴关系，并探讨开展名为 “Origene一体化报告” 的遗传筛查服务的可能性，包括一种名为 “儿童期发病概况” 的衍生产品，用于相应疾病的细胞基因疗法
In a Bursa filing today, the first was expressed as a Strategic Collaboration Agreement (SCA) with Kumpulan Perubatan Penawar Sdn Bhd (KPPSB); and secondly, a SCA with Hospital Penawar Sdn Bhd (HPSB).
在今天的Bursa文件中，第一份是与Kumpulan Perubatan Penawar Sdn Bhd（KPPSB）签订的战略合作协议（SCA）；其次是与佩纳瓦尔医院私人有限公司（HPSB）签订的SCA。
The key indicative obligations of the collaborations include MGRCH shall provide consultancy services and technical support for the Project which includes genetic screen-testing services and providing material and literature for the marketing and promotion of the Project by KPPSB and HPSB.
合作的主要指示性义务包括MGRCH应为该项目提供咨询服务和技术支持，其中包括基因筛查测试服务，以及为KPPsB和HpSb的项目营销和推广提供材料和文献。
KPPSB and HPSB shall have the distribution rights to provide the Product through their healthcare facilities and shall be providing consultancy services to consumers, and MGRCH, KPPSB and HPSB shall collaborate to explore the cell-gene therapies in childhood-onset disease.
KppsB和HpSb应拥有通过其医疗机构提供产品的分销权，并应向消费者提供咨询服务，MGRCH、KppsB和HpSb应合作探索儿童发作疾病的细胞基因疗法。
MGRC is a public limited company incorporated in Malaysia and listed on the ACE Market of Bursa Malaysia Securities Berhad, with its principal activities in providing personalised and precision health solutions through genetics, genomics, immunotherapy and biopharmaceutical services as well as an investment holding company.
MGRC是一家在马来西亚注册的上市有限公司，在马来西亚证券交易所的ACE市场上市，其主要业务是通过遗传学、基因组学、免疫疗法和生物制药服务提供个性化和精准的健康解决方案，也是一家投资控股公司。
While, MGRCH is a wholly owned subsidiary of the Company, with its principal activities in supplying healthcare products and services.
同时，MGRCH是该公司的全资子公司，其主要业务是提供医疗保健产品和服务。
KPPSB is a healthcare group offering polyclinic and hospital services related to medical services such as Pharmacy, Psychiatric Specialist Clinic, Occupational Health Services, Dialysis Centre and other services in multiple locations within Johor. HPSB HPSB is a boutique hospital catering to the surrounding community and selected niche markets, offering an extensive array of specialised clinics with more than 20 specialists across a wide range of medical and surgeries disciplines to meet a wide range of unique healthcare requirements.
KppsB是一家医疗保健集团，在柔佛州的多个地点提供与医疗服务相关的综合诊所和医院服务，例如药房、精神科专科诊所、职业健康服务、透析中心和其他服务。HpSb HpSb是一家精品医院，面向周边社区和选定的利基市场，提供种类繁多的专科诊所，拥有20多名专科医生，涵盖各种医学和外科领域，可满足各种独特的医疗保健需求。
The Parties are of the view that there are synergistic benefits to be derived for the SCAs through sharing and developing the knowledge and expertise of both parties in relation to the Product, which is subject to the terms and conditions of the SCAs.
双方认为，通过分享和发展双方在产品方面的知识和专长，SCA可以获得协同效益，这要受SCA的条款和条件的约束。